IDEXX Laboratories, Inc. (IDXX)
NASDAQ • Healthcare
October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, IDEXX Laboratories, Inc. keeps $28 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 2
in 29 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
IDEXX Laboratories topped consensus on both revenue and earnings in the second fiscal quarter of 2026, reported Aug. 4, as revenue rose about 10% to roughly $1.2 billion and EPS came in at $4.27. Revenue exceeded the $1.20 billion estimate by 1.4%, while EPS topped the $3.94 consensus by 8.4% and was up about 18% from $3.63 a year ago. Net income increased about 15% to roughly $338 million from $294.0 million a year earlier, and gross profit reached about $779 million with gross margin near 64% and operating margin around 35%; operating income came in at roughly $426 million. The company generated operating cash flow of $347.2 million and repurchased about $347 million of stock. Consensus for the next period calls for EPS of $3.77 on revenue of $1.19 billion.
Next report — what to expect
IDEXX Laboratories Inc (IDXX) is scheduled to report earnings on November 2, 2026. Wall Street is looking for consensus EPS of $3.71 on consensus revenue of $1.19 billion. For trailing context, revenue grew +9.7% year over year last quarter. IDEXX has beaten EPS in 8 of 8 most recent quarters.
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. (NASDAQ: IDXX) develops diagnostic and information products for animal health and water testing within the medical diagnostics and research business, generating $4.3 billion in FY2025 revenue. Its work spans veterinary care, livestock and dairy monitoring, biomedical research support, and microbiological testing tools used in water quality programs worldwide.
Today's Snapshot
The day ended with IDXX slightly higher at 518.39, in line with a flat sector. Shares changed hands at about two-thirds of its usual level.
Trading Volume
Below 10d avg (415.3K)
287.6K
vs S&P 500 Today
Underperforming Market
-0.66%
Updated: October 2, 2026 at 20:17 UTC
IDXX Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$520.78 - $589.71Sell
- RSI (14)44.71Neutral
- Stochastic %K (14, 3, 3)50.63Neutral
- MACD Level (12, 26)-5.42Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.